Literature DB >> 27124588

Giemsa is the optimal counterstain for immunohistochemical detection of BRAF V600E mutation status in pigmented melanomas.

Sanjita Ravishankar1, Priyadharsini Nagarajan1, Jonathan L Curry1, Michael T Tetzlaff1, Doina Ivan1, Carlos A Torres-Cabala1, Phyu P Aung1, Victor G Prieto2.   

Abstract

Entities:  

Keywords:  BRAF V600E; Giemsa; immunodetection; melanin; melanoma

Mesh：

Substances：

Year:  2016        PMID： 27124588     DOI： 10.1111/cup.12714

Source DB:  PubMed          Journal:  J Cutan Pathol        ISSN： 0303-6987            Impact factor:   1.587


× No keyword cloud information.
  2 in total

1.  Rapid BRAF mutation tests in patients with advanced melanoma: comparison of immunohistochemistry, Droplet Digital PCR, and the Idylla Mutation Platform.

Authors:  Cornelis Bisschop; Arja Ter Elst; Lisette J Bosman; Inge Platteel; Mathilde Jalving; Anke van den Berg; Arjan Diepstra; Bettien van Hemel; Gilles F H Diercks; Geke A P Hospers; Ed Schuuring
Journal:  Melanoma Res       Date:  2018-04       Impact factor: 3.599

2.  Construction of hematoxylin-eosin, immunohistochemistry, and EBER-ISH methodology after trichloroisocyanuric acid treatment in melanin-containing tissues.

Authors:  Chaoshan Wang; Xia Yang; Ting Wang; Ya Wang; Jiong Shi; Qi Sun; Yihua Wang; Hongyan Wu
Journal:  Sci Rep       Date:  2022-09-26       Impact factor: 4.996
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.